MELINDA WELCH: Open Payments
NPI 1639881436 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 9 payments from 7 companies in 2025. Trend: 2023 $154 · 2024 $17 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $57 |
| Incyte Corporation | 2 | $44 |
| ABBVIE INC. | 1 | $32 |
| Eisai Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| KYOWA KIRIN, INC. | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
Products named: KEYTRUDA, ELAHERE, Lenvima, ZYNYZ, MONJUVI, POTELIGEO, Tecentriq.
Industry payments across CA — which companies pay providers there.
